SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001401708-20-000110
Filing Date
2020-05-08
Accepted
2020-05-08 16:49:12
Documents
57
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nstg-10q.htm   iXBRL 10-Q 1409016
2 EXHIBIT 31.1 nstg-ex311.htm EX-31.1 12716
3 EXHIBIT 31.2 nstg-ex312.htm EX-31.2 12658
4 EXHIBIT 32.1 nstg-ex321.htm EX-32.1 8007
5 EXHIBIT 32.2 nstg-ex322.htm EX-32.2 7145
  Complete submission text file 0001401708-20-000110.txt   5783991

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nstg-20200331.xsd EX-101.SCH 34540
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nstg-20200331_cal.xml EX-101.CAL 74406
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nstg-20200331_def.xml EX-101.DEF 194121
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nstg-20200331_lab.xml EX-101.LAB 518133
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nstg-20200331_pre.xml EX-101.PRE 305448
51 EXTRACTED XBRL INSTANCE DOCUMENT nstg-10q_htm.xml XML 900657
Mailing Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109
Business Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109 206-378-6266
NanoString Technologies Inc (Filer) CIK: 0001401708 (see all company filings)

IRS No.: 200094687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35980 | Film No.: 20861356
SIC: 2836 Biological Products, (No Diagnostic Substances)